TGFB1 and metabolic dysfunction-associated steatohepatitis: Important roles for TGF-β have been shown in fibrotic diseases such as kidney fibrosis, non-alcoholic steatohepatitis, and systemic sclerosis, suggesting potential applicability for other indications to measure TGF-β [9,10,11].